DOUGLAS GRIFFITH: Open Payments
NPI 1871551671 · DALHART, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 10 payments from 7 companies in 2025. Trend: 2023 $102 · 2024 $441 · 2025 $1,276
Food & beverage: $1,276
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $374 |
| Abbott Laboratories | 2 | $335 |
| Stryker Corporation | 1 | $122 |
| GENZYME CORPORATION | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| SANOFI US SERVICES INC. | 1 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $100 |
Products named: Auvelity, INFINITY, FREESTYLE LIBRE 3, CLOTTRIEVER BOLD CATHETER, DUPIXENT, AYVAKIT, XIFAXAN.
Industry payments across TX — which companies pay providers there.
